Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Total Liabilities (2016 - 2025)

INVO Fertility has reported Total Liabilities over the past 16 years, most recently at $13.0 million for Q3 2025.

  • Quarterly Total Liabilities fell 23.82% to $13.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.0 million through Sep 2025, down 23.82% year-over-year, with the annual reading at $26.2 million for FY2024, 49.01% up from the prior year.
  • Total Liabilities was $13.0 million for Q3 2025 at INVO Fertility, down from $16.7 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $26.2 million in Q4 2024 and troughed at $2.5 million in Q1 2022.
  • The 5-year median for Total Liabilities is $6.6 million (2023), against an average of $11.0 million.
  • Year-over-year, Total Liabilities tumbled 49.13% in 2022 and then surged 459.65% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $2.7 million in 2021, then skyrocketed by 74.69% to $4.7 million in 2022, then surged by 275.75% to $17.6 million in 2023, then skyrocketed by 49.01% to $26.2 million in 2024, then plummeted by 50.53% to $13.0 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Total Liabilities are $13.0 million (Q3 2025), $16.7 million (Q2 2025), and $24.4 million (Q1 2025).